Yield10 Yield10 Bioscience, Inc. www.yield10bio.com NASDAQ: YTEN HC Wainwright Bioconnect Virtual Conference Today Jan. 10-13, 2022 Sustainable Growth Starts with a Seed Safe Harbor Statement* Today 2 The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe th ...

Yield10 Third Quarter 2021 Financial Results and Business Highlights Today Nov. 10, 2021 Yield10 Bioscience, Inc. www.yield10bio.com NASDAQ: YTEN Sustainable Growth Starts with a Seed Safe Harbor Statement* Today 2 The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statemen ...

Yield10 Bioscience, Inc. (OTCQB:YTEN) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Lynne Brum - Vice President, Planning and Corporate Communications Ollie Peoples - President and Chief Executive Officer Kristi Snell - Vice President of Research and Chief Science Officer Chuck Haaser - Chief Accounting Officer Conference Call Participants Jeremy Pearlman - Maxim Operator Welcome to the Third Quarter 2021 Financial Results and Business Update Conference Call for Yield10 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33133 YIELD10 BIOSCIENCE, INC. (State or other jurisdiction of incorporation or organization) 19 Presidential Way Woburn, MA 01801 (Ad ...

Yield10 Yield10 Bioscience, Inc. www.yield10bio.com NASDAQ: YTEN Second Quarter 2021 Financial Results and Business Highlights Today Aug 11, 2021 Sustainable Growth Starts with a Seed Safe Harbor Statement* Today 2 The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statemen ...

Yield10 Bioscience, Inc. (OTCQB:YTEN) Q2 2021 Earnings Conference Call August 11, 2021 4:30 PM ET Company Participants Lynne Brum - Vice President of Planning & Corporate Communications Oliver Peoples - President & Chief Executive Officer Kristi Snell - Vice President of Research & Chief Science Officer Conference Call Participants Anthony Vendetti - Maxim Group Ben Klieve - Lake Street Capital Markets Operator Welcome to the Second Quarter 2021 Financial Results and Business Update Conference Call for Yiel ...

Commission file number 001-33133 YIELD10 BIOSCIENCE, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (State or other jurisdiction of incorporation or organization) 19 Presidential Way Woburn, MA 01801 (Address ...

Yield10 Yield10 Bioscience, Inc. NasdaqCM: YTEN First Quarter 2021 Financial Results and Business Highlights www.yield10bio.com Crop Innovations For Sustainable Food Security Today May 11, 2021 2 Safe Harbor Statement* The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking stat ...

Yield10 Bioscience, Inc. (OTCQB:YTEN) Q1 2021 Earnings Conference Call May 11, 2021 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Snell – Vice President of Research and Chief Science Officer Conference Call Participants Anthony Vendetti – Maxim Group Amit Dayal – H.C. Wainwright Operator Welcome to the First Quarter 2021 Financial Results and Business Update Conference Call for Yield10 Biosci ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33133 YIELD10 BIOSCIENCE, INC. (State or other jurisdiction of incorporation or organization) 19 Presidential Way Woburn, MA 01801 (Address of principal executive offices) (Zip Code) Delaware 04-3158289 (I.R.S. Employer Identification No.) ...